Zentalis Pharmaceuticals, Inc. (ZNTL) scores 23 out of 100 on boothcheck's 11-model valuation framework. Verdict: Bad The estimated fair value is $0.00. Quantitative score: 34/100. Qualitative score: 40/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.